Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Ensysce Biosciences Inc (ENSC)

Ensysce Biosciences Inc (ENSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ensysce Biosciences, Inc. Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds ACCESS Newswire - Thu Apr 24, 11:15AM CDT

SAN DIEGO, CA / ACCESS Newswire / April 24, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) (the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief...

ENSC : 1.1000 (-0.90%)
Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds ACCESS Newswire - Wed Apr 23, 11:41AM CDT

SAN DIEGO, CALIFORNIA / ACCESS Newswire / April 23, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) (the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain...

ENSC : 1.1000 (-0.90%)
Ensysce Biosciences Receives U.S. Patent for Groundbreaking Treatment of Opioid Use Disorder ACCESS Newswire - Wed Apr 23, 3:00AM CDT

~ Applies TAAP and MPAR Technology to Produce Novel OUD Treatments ~

ENSC : 1.1000 (-0.90%)
Ensysce Biosciences Stock Rises On Positive Data From Opioid Overdose Protection Study: Retail’s Thrilled Stocktwits - Tue Apr 15, 1:40PM CDT

The company stated that a 100 mg dosage of PF614-MPAR delivers oxycodone to treat severe pain and provides overdose protection when a greater-than-prescribed dose is consumed.

VXF : 213.38 (-0.19%)
ENSC : 1.1000 (-0.90%)
Ensysce Biosciences Announces Positive Data from Opioid Overdose Protection Study ACCESS Newswire - Tue Apr 15, 3:00AM CDT

~ Additional Evidence of PF614-MPAR Overdose Protection after Completion of Part 1 of Clinical Study ~

ENSC : 1.1000 (-0.90%)
Ensysce Biosciences, Inc. Announces $1.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules ACCESS Newswire - Mon Mar 31, 3:00AM CDT

SAN DIEGO, CA / ACCESS Newswire / March 31, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe...

ENSC : 1.1000 (-0.90%)
Ensysce Biosciences Announces PAINWeek 2025 Symposium and Recent Expert Panel Discussion on The State of the Nation in Pain ACCESS Newswire - Tue Mar 18, 3:00AM CDT

~ Analgesic Experts Consider Pain Indications Versus New Classes of Analgesics ~

ENSC : 1.1000 (-0.90%)
Ensysce Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results ACCESS Newswire - Mon Mar 10, 11:15AM CDT

Secures Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPAR

ENSC : 1.1000 (-0.90%)
Ensysce Biosciences to Participate in the 37th Annual ROTH Conference ACCESS Newswire - Wed Mar 5, 2:00AM CST

SAN DIEGO, CA / ACCESS Newswire / March 5, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe...

ENSC : 1.1000 (-0.90%)
Ensysce Biosciences Reports Continued Positive Progress in Groundbreaking Trial on PF614-MPAR, Comments on Current Landscape for Pain Treatment ACCESS Newswire - Wed Feb 5, 2:00AM CST

~ Positive Enrollment Progress and Safety Data ~

ENSC : 1.1000 (-0.90%)

Barchart Exclusives

The Saturday Spread: Using Risk Topography to Plan Your Options Strategies (JD, NTAP, ZS) Barchart - 54 minutes ago
While derivatives offer significant upside potential, trading these contracts requires precision. Here’s how to get a leg up, even against Wall Street pros. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot